FTA-ABS Test Explained: Interpretation Guide
🧪 FTA-ABS Test: Complete Guide (Purpose, IFA Method, Clinical Significance, Interpretation)
The essential treponemal confirmatory test for diagnosing syphilis
📝 Description
FTA-ABS test is the key treponemal confirmatory test for diagnosing syphilis. Learn its purpose, IFA method, clinical significance, interpretation tips, and essential cautions for accurate diagnosis.
🧫 FTA-ABS Test: Complete Guide
The FTA-ABS (Fluorescent Treponemal Antibody Absorption) test is one of the most important treponemal confirmatory tests used to diagnose Treponema pallidum infection (syphilis).
It is typically performed following a reactive non-treponemal test such as RPR or VDRL to confirm infection with high specificity.
1. What Is the FTA-ABS Test?
The FTA-ABS test detects specific IgG and IgM antibodies against Treponema pallidum using an indirect fluorescent antibody (IFA) method.
Because of its high specificity, the test has been used worldwide as a standard confirmatory method for decades.
Key Characteristics
- Treponemal confirmatory test
- Detects infection early (1–2 weeks after exposure)
- Remains positive for years or lifelong after treatment
- Extremely high specificity (very low false-positive rate)
2. Purpose of Testing
✔ 1) Confirming syphilis after RPR/VDRL positive
The standard algorithm requires a treponemal test after any non-treponemal reactive result.
✔ 2) Distinguishing biological false positives
RPR/VDRL may be falsely positive in:
- Pregnancy
- Autoimmune disease
- Elderly patients
FTA-ABS clarifies true infection.
✔ 3) Evaluating latent or late-stage syphilis
Antibodies persist across all stages, including latent and tertiary syphilis.
✔ 4) Assisting in neurosyphilis evaluation
CSF FTA-ABS is highly sensitive, useful when CSF-VDRL is negative but suspicion remains.
3. Testing Method – IFA (Indirect Fluorescent Antibody)
FTA-ABS is performed using the indirect immunofluorescence method.
Test Procedure
- T. pallidum antigen is fixed on the slide.
- Patient serum is applied, allowing antibodies to bind.
- Absorption step removes non-specific cross-reactive antibodies.
- Fluorescent-labeled anti-human IgG/IgM is added.
- Fluorescence is visualized under a microscope.
- Positive fluorescence = reactive/positive result.
Advantages
- Very high specificity
- Detects early primary infection
- Standardized and widely validated
4. Clinical Significance
✔ 1) Gold-standard confirmatory test
Used to definitively confirm syphilis following a positive screening test.
✔ 2) Positive regardless of disease stage
Reactive in:
- Primary syphilis
- Secondary syphilis
- Latent syphilis
- Tertiary syphilis
✔ 3) Persistent antibodies
Even after successful treatment, antibodies usually persist for life.
✔ 4) Supportive role in neurosyphilis
CSF FTA-ABS:
- High sensitivity
- Good complementary test to CSF-VDRL
✔ 5) Identifying false-positive RPR/VDRL cases
Useful in autoimmune disease, pregnancy, and viral infections.
5. Interpretation of Results
Positive (Reactive)
- Indicates Treponema pallidum infection (past or present)
- Cannot differentiate current vs. past infection
- Combine with RPR/VDRL titers to assess disease activity
Negative (Non-reactive)
- Syphilis unlikely
- However: early primary infection can be falsely negative
→ Re-test in 2–4 weeks if clinically suspected
Borderline / Indeterminate
- Low antibody levels
- Could indicate early infection or remote resolved infection
→ Perform additional treponemal test (TP-PA, EIA)
6. Critical Points for Interpretation
⚠ 1) Not for treatment monitoring
FTA-ABS stays positive for life → cannot be used to assess treatment response
→ Use RPR/VDRL titers instead.
⚠ 2) False negatives possible in very early infection
Antibodies may not yet be produced.
⚠ 3) Rare false positives
Although uncommon, may occur in:
- Systemic lupus erythematosus (SLE)
- Antiphospholipid syndrome
⚠ 4) HIV co-infection
Delays in antibody production may occur → interpret serology carefully.
⚠ 5) Requires experienced interpretation
Fluorescence intensity is subjective and depends on operator training.
7. Quick Summary
| 항목 | 내용 |
|---|---|
| Test type | Treponemal confirmatory test |
| Method | IFA (indirect fluorescent antibody) |
| Strengths | High specificity, early detection |
| Limitations | Lifelong positivity → not useful for treatment monitoring |
| Main uses | Confirming syphilis, neurosyphilis evaluation |
| Cautions | Early false negatives, careful interpretation in HIV |
8. References
- CDC. Syphilis: Laboratory Recommendations and Guidelines.
- Larsen SA, Steiner BM, Rudolph AH. Clin Microbiol Rev.
- WHO. Laboratory Diagnosis of Sexually Transmitted Infections.
- Sena AC, White BL, Sparling PF. Syphilis. Lancet. 2010.
- Workowski KA. CDC STD Treatment Guidelines.